CFN Insider explores how the U.S. cannabis industry is evolving and the potential impact of a DEA decision to reschedule the drug or its cannabinoid constituents with a leading market analyst and group of five legal experts. In addition, invest
CFN Insider explores the branding principle in cannabis and how it's ever more critical with recreational legalization in California and soon in Canada while big national brands make inroads. Three experts from influential cannabis brands give
CFN Insider looks at California's recreational market, which is poised to become the largest legal cannabis industry in the world. In addition, experts take a look at the elections earlier this month and how the results might impact the cannabi
The Cole Memo and other regulations have tried to open up banking access to the cannabis industry, but many banks and credit unions refuse to engage with the marijuana industry because it remains a Schedule I Controlled Substance. In this episo
The opioid epidemic has reached a critical point in the United States, with more than 60,000 Americans dying from overdose last year alone. In July 2017, opioid addiction was cited as the "FDA's biggest crisis" and CDC Director Thomas Frieden s
CFN Insider looks at where medical marijuana may be headed on a federal level and whether the industry has reached a critical mass. In addition, this episode looks at the status of legalization in other markets across North America and Europe.